The PAV trial: Does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277]

BMC Family Practice

Volumn 5, Issue , 2004, Pages 1-8

  Pirotta, Marie ^a   Gunn, Jane ^a   Chondros, Patty ^a   Grover, Sonia ^b   Hurley, Susan ^c   Garland, Suzanne ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c Bainbridge Consultants Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FEMILAC; LACTOBAC; PLACEBO; PROBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BIFIDOBACTERIUM LONGUM; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFECTION; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS THERMOPHILUS; VAGINA CANDIDIASIS; VAGINA SMEAR; VULVOVAGINITIS;

EID: 2942572787     PISSN: 14712296     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2296-5-5     Document Type: Article

References (29)

1. MacLennan A, Wilson D, Taylor A: The Escalating Cost and Prevalence of Alternative Medicine. Preventive Medicine 2002, 35:166-173.
2. Eisenberg D, Davis R, Ettner S, Appel S, Wilkey S, Van Rompay M, Kessler R: Trends in alternative medicine use in the United States, 1990-1997. JAMA 1998, 280:1569-1575.
3. Anonymous: Complementary medicine: time for critical engagement. Lancet 2000, 356:2023.
4. Angell M, P Jerome: Alternative Medicine - The Risks of Untested and Unregulated Remedies. New England Journal of Medicine 1998, 339:839-841.
5. Wroe D: Alternative health care under fire. The Age Melbourne; 2003:5.
6. McCarthy M: US panel calls for more support of alternative medicine. Lancet 2002, 359:1213.
7. Nahin R, Straus S: Research into complementary and alternative medicine: problems and potential. BMJ 2001, 322:161-164.
8. Ernst E: Obstacles to research in complementary and alternative medicine. MJA 2003, 179:279.
9. Adams J, Sibbritt D, Easthope G, Young A: The profile of women who consult alternative health practitioners in Australia. MJA 2003, 179:297-300.
10. Pirotta M, Gunn J, Chondros P: "Not thrush again!" Women's experience of post-antibiotic vulvovaginitis. Med J Aust 2003, 179:43-46.
11. Bluestein D, Rutledge C, Lumsden L: Predicting the occurrence of antibiotic-induced candidal vaginitis (AICV). Fam Pract Res J 1991, 11:319-326.
12. Nyirjesy P, Weitz M, Grody T, Lorber B: Over-the-counter and alternative medicines in the treatment of chronic vaginal symptoms. Obstet Gynecol 1997, 90:50-53.
13. Lipsky MS, Taylor C: The use of over-the-counter antifungal vaginitis preparations by college students. Family Medicine 1996, 28:493-495.
14. Pizzorno L, Pizzorni J, Murray M: Natural Medicine Instructions for Patients. Churchill Livingstone; 2002.
15. Friedlander A, Druker MM, Schachter A: Lactobacillus acidophillus and vitamin B complex in the treatment of vaginal infection. Panminerva Medica 1986, 28:51-53.
16. Hilton E, Isenberg HD, Alperstein P, France K, Borenstein MT: Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Annals of Internal Medicine 1992, 116:353-357.
17. Hilton E, Rindos P, Isenberg HD: Lactobacillus GG vaginal suppositories and vaginitis. J Clin Microbiol 1995, 33:1433.
18. Shalev E, Battino S, Weiner E, Colodner R, Keness Y: Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996, 5:593-596.
19. Williams AB, Yu C, Tashima K, Burgess J, Danvers K: Evaluation of two self-care treatments for prevention of vaginal candidiasis in women with HIV. Journal of the Association of Nurses in AIDS Care 2001, 12:51-57.
20. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR: Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998, 178:203-211.
21. Dennerstein GJ, Ellis DH: Oestrogen, glycogen and vaginal candidiasis. Australian & New Zealand Journal of Obstetrics & Gynaecology. 2001,41:326-328.
22. MacDonald TM, Beardon PH, McGilchrist MM, Duncan ID, McKendrick AD, McDevitt DG: The risks of symptomatic vaginal candidiasis after oral antibiotic therapy. Quarterly Journal of Medicine 1993, 86:419-424.
23. McGroarty JA: Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunology & Medical Microbiology 1993, 6:251-264.
24. Gilliland M: Instability of Lactobacillus acidophilus in yogurt. J Diary Science 1977, 60:1394-1398.
25. Bernal S, Mazuelos EM, Garcia M, Aller AI, Martinez MA, MJ. Gutierrez: Evaluation of CHROMagar Candida medium for the isolation of presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis 1996, 24:201-204.
26. Hospenthal DR, Murray CK, Beckius ML, Green JA, Dooley DP: Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium. J Clin Micro 2002, 40:4768-4770.
27. StataCorp: Stata Statistical Software. 7th edition. College Station, Texas, Stata Corporation; 2001.
28. O'Brien P, Fleming T: A multiple testing procedure for clinical trials. Biometrics 1979, 35:549-556.
29. Hetherington J, Dickersin K, Chalmers I, Meinert C: Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians. Pediatrics 1989, 84:374-380.